Spider Rock Advisors, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Spider Rock Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 01, 2024	SELL	$1024.09 - $1201.76 $409,635 - $480,704	-400 Reduced 16.67%	2,000 $2.1 Million
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $88,320 - $107,119	-100 Reduced 4.0%	2,400 $2.52 Million
Q2 2022 Aug 03, 2022	BUY	$548.35 - $738.84 $1.37 Million - $1.85 Million	2,500 New	2,500 $1.48 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $896,575 - $1.17 Million	-2,500 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$431.38 - $504.0 $1.08 Million - $1.26 Million	2,500	2,500 $113,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spider Rock Advisors, LLC with notifications on news.